Sanofi Agrees to Transfer Infectious Disease Unit, 100 Employees to Evotec

Sanofi has agreed to transfer its infectious disease unit, and most of its research portfolio and initiatives, to Evotec for more than €60 million (nearly $70 million), in a deal that Evotec said today will more than double its workforce in the indication, and will transform it into a leading developer of anti-infective treatments.Evotec said it will license from Sanofi “more than 10” infectious disease R&D assets, comprising the majority of the pharma giant’s infectio